Horn & Co. has significant, recognized expertise in life sciences, medical devices, internet, software, telecommunications, and cleantech. The firm has been consistently ranked by international reviews (Legal 500, Who’s Who Legal, IAM, DUNS) as one of Israel’s leading practices in intellectual property transactions. With a thorough understanding of the specific complexities and needs of technology-based, long-haul development companies, the firm represents clients in all aspects of strategic transactions.
Our experience includes drafting, negotiating and advising on the various types of IP related agreements, including:
• License, license option, joint development and prototype agreements with companies including J&J, Mayo Clinic, Pfizer, Edwards, Medtronic, Teva, Yahoo Japan, Dell, Bosch, InterMountain Health, Cleveland Clinic, GE Medical, Smith and Nephew, Duoyuan.
• Data license agreements with leading healthcare providers, insurers and companies.
• Representation of software companies in their in and out licensing, co development, procurement and related matters;
• Licensing transactions with technology transfer companies of academic institutions and hospitals in Israel and outside of Israel;
• Clinical trial agreements and CRO agreements with dozens of medical centers worldwide; and
• Manufacturing agreements.
Horn & Co. was chosen as the Israeli representative to Biolegis, the European network of leading law firms specializing in biotechnology and medical devices, in which one firm from each country is represented (BIOLEGIS). Yuval Horn is the former co-Chair and current member of the SAB of the International Bar Association (IBA) Technology Law Committee. Yuval has been a member of the Sheba Medical Center IRB (Helsinki Committee), since 2007, and its Procurement Committee since 2020.